Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,645 INR | -1.37% | +0.78% | -2.22% |
02-09 | India's Zydus Lifesciences beats Q3 profit estimates; approves shares buyback | RE |
02-08 | Transcript : Zydus Wellness Limited, Q3 2024 Earnings Call, Feb 08, 2024 |
Sales 2024 * | 23.19B 278M 22.13B | Sales 2025 * | 26.27B 315M 25.08B | Capitalization | 105B 1.25B 99.91B |
---|---|---|---|---|---|
Net income 2024 * | 2.9B 34.83M 2.77B | Net income 2025 * | 3.95B 47.35M 3.77B | EV / Sales 2024 * | 4.49 x |
Net cash position 2024 * | 566M 6.79M 540M | Net cash position 2025 * | 2.8B 33.54M 2.67B | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
35.2
x | P/E ratio 2025 * |
26.5
x | Employees | 975 |
Yield 2024 * |
0.45% | Yield 2025 * |
0.62% | Free-Float | 20.12% |
Latest transcript on Zydus Wellness Limited
1 day | -1.37% | ||
1 week | +0.78% | ||
Current month | +11.83% | ||
1 month | +11.83% | ||
3 months | +2.60% | ||
6 months | +5.93% | ||
Current year | -2.22% |
Managers | Title | Age | Since |
---|---|---|---|
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 13/05/15 |
Umesh V. Parikh
DFI | Director of Finance/CFO | - | 06/02/18 |
Compliance Officer | - | 28/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 26/04/09 | |
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 13/05/15 |
Director/Board Member | 50 | 10/03/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.47% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1,645 | -1.37% | 1 149 |
26/04/24 | 1,668 | -0.38% | 2,106 |
25/04/24 | 1,674 | +1.50% | 1,306 |
24/04/24 | 1,649 | +1.04% | 688 |
23/04/24 | 1,632 | -1.61% | 1,032 |
Delayed Quote Bombay S.E., April 29, 2024 at 11:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.22% | 1.27B | |
-5.57% | 266B | |
-1.06% | 94.98B | |
+4.10% | 46.39B | |
+7.58% | 39.99B | |
-0.03% | 39.95B | |
+2.19% | 38.02B | |
-16.08% | 30.16B | |
-5.60% | 28.72B | |
+12.13% | 24.54B |
- Stock Market
- Equities
- ZYDUSWELL Stock